Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Depreciation & Amortization (CF) (2021 - 2026)

Analysis

Starling Oncology (STLN) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn 944.00 Mn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn 215.00 Mn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn 90.40 Mn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn -
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn 167.34 Mn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn 31.41 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 16.99 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn -
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn 19.90 Mn
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn 1.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.84 Mn
Mar 31, 2026 1.62 Mn
Dec 31, 2025 1.63 Mn
Sep 30, 2025 1.72 Mn
Jun 30, 2025 1.81 Mn
Mar 31, 2025 1.78 Mn
Dec 31, 2024 1.71 Mn
Sep 30, 2024 1.57 Mn
Jun 30, 2024 1.52 Mn
Mar 31, 2024 1.49 Mn
Dec 31, 2023 1.58 Mn
Sep 30, 2023 1.70 Mn
Jun 30, 2023 1.33 Mn
Mar 31, 2023 1.27 Mn
Dec 31, 2022 1.19 Mn
Sep 30, 2022 1.13 Mn
Jun 30, 2022 1.10 Mn
Mar 31, 2022 987,000.00
Dec 31, 2021 920,000.00
Sep 30, 2021 850,000.00